Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Clinical trial NCT00035256 · COMPLETED
Trial details
- NCT number
- NCT00035256
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.